Lahouaria Hadri

Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension.

Characterization of right ventricular remodeling and failure in a chronic pulmonary hypertension model.

Combination proximal pulmonary artery coiling and distal embolization induces chronic elevations in pulmonary artery pressure in Swine.

Intratracheal Gene Delivery of SERCA2a Ameliorates Chronic Post-Capillary Pulmonary Hypertension: A Large Animal Model.

Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability.

Inhaled Gene Transfer for Pulmonary Circulation.

CXCR4 and CXCR7 play distinct roles in cardiac lineage specification and pharmacologic β-adrenergic response.

Pulmonary hypertension arising from left heart disease causes intrapulmonary venous arterialization in rats.

Pulmonary Artery Hypertension Model in Rats by Monocrotaline Administration.

The Sugen 5416/Hypoxia Mouse Model of Pulmonary Arterial Hypertension.

Direct measurement of left atrial and pulmonary artery pressure in rats with pulmonary hypertension.

Safety and long-term efficacy of AAV1.SERCA2a using nebulizer delivery in a pig model of pulmonary hypertension.

Intra-tracheal gene delivery of aerosolized SERCA2a to the lung suppresses ventricular arrhythmias in a model of pulmonary arterial hypertension.

CXCR4 Cardiac Specific Knockout Mice Develop a Progressive Cardiomyopathy.

A novel secreted-cAMP pathway inhibits pulmonary hypertension via a feed-forward mechanism.

AAV1.SERCA2a Gene Therapy Reverses Pulmonary Fibrosis by Blocking the STAT3/FOXM1 Pathway and Promoting the SNON/SKI Axis.

Targeting epigenetic mechanisms as an emerging therapeutic strategy in pulmonary hypertension disease.